Dividend income
-
Earnings per share
-3.89 $
Price/earnings (P/E)
-
Capitalization
40.33 billion $
Sector
Healthcare
Shares outstanding
187.7 million
Capitalization
40.33 billion $
Price/earnings (P/E)
-
Earnings per share
-3.89 $
Dividend rate
-
Dividend income
-
Seagen Inc. - is a biotechnology company that develops monoclonal antibody-based drugs for the treatment of cancer and related diseases, and also offers antibody-drug conjugate technology to deliver drugs directly to tumor cells. The company serves customers in the northwestern United States. Founded in 1998 in the USA.